Dr. Mark Galantowicz, MD
Claim this profileNationwide Children's Hospital
Studies Congenital Heart Defects
Studies Heart Disease
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Mark Galantowicz, MD is currently running
Tissue Engineered Vascular Grafts
for Heart Disease
A single arm clinical trial evaluating the safety and efficacy of the second generation TEVG as vascular conduits for extracardiac total cavopulmonary connection.
Recruiting1 award Phase 22 criteria
Pulmonary Valve Replacement
for Congenital Heart Disease
This trial tests a special heart valve that can grow with children who need a new pulmonary valve. The valve can be resized before and after it is placed in the heart, reducing the need for multiple surgeries.
Recruiting1 award N/A9 criteria
More about Mark Galantowicz, MD
Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mark Galantowicz, MD has experience with
- Second-Generation Tissue Engineered Vascular Grafts
- Autus Size-Adjustable Valve
Breakdown of trials Mark Galantowicz, MD has run
Congenital Heart Defects
Heart Disease
Heart disease
Tricuspid Atresia
Double Outlet Right Ventricle
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Galantowicz, MD specialize in?
Mark Galantowicz, MD focuses on Congenital Heart Defects and Heart Disease. In particular, much of their work with Congenital Heart Defects has involved treating patients, or patients who are undergoing treatment.
Is Mark Galantowicz, MD currently recruiting for clinical trials?
Yes, Mark Galantowicz, MD is currently recruiting for 2 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Mark Galantowicz, MD has studied deeply?
Yes, Mark Galantowicz, MD has studied treatments such as Second-Generation Tissue Engineered Vascular Grafts, Autus Size-Adjustable Valve.
What is the best way to schedule an appointment with Mark Galantowicz, MD?
Apply for one of the trials that Mark Galantowicz, MD is conducting.
What is the office address of Mark Galantowicz, MD?
The office of Mark Galantowicz, MD is located at: Nationwide Children's Hospital, Columbus, Ohio 43205 United States. This is the address for their practice at the Nationwide Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.